Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,034,863
-$1,091,013 QoQ
Shares Held
209,089
-4.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#599
of 2,821 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. PFE ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
This page
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,034,863 | 209,089 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,125,876 | 218,158 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,619,681 | 225,690 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,682,549 | 223,020 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,133,671 | 170,531 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $3,290,014 | 113,684 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,798,033 | 135,741 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,621,932 | 58,448 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,293,765 | 44,938 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,061,681 | 62,155 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,271,078 | 61,916 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,996,956 | 48,945 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,223,713 | 43,398 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,696,312 | 38,764 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,243,846 | 42,797 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,659,901 | 32,063 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,614,367 | 27,339 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,150,603 | 26,752 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $953,624 | 24,352 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $856,948 | 23,653 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $932,507 | 25,333 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $757,365 | 23,161 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $725,423 | 22,225 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||